As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A NEW Phase 3 trial has shown that a combination therapy of cagrilintide and semaglutide (CagriSema) can lead to substantial ...

The drugs are now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as potential vision loss.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Ozempic can help manage type 2 diabetes, but it's also becoming increasingly popular for weight loss, which is an off-label use. Clinical trials show that Ozempic's active ingredient, semaglutide ...